Skip to main content

Find Clinical Trials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

367 public trials 125 recruiting studies

Refine in advanced search Browse all conditions

NSCLC trial results

Completed

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

NCT04720976

Conditions: NSCLC, Solid Tumor
Locations: Research Site Phoenix, Arizona, United States

Research Site Scottsdale, Arizona, United States

Research Site Los Angeles, California, United States

Research Site New Haven, Connecticut, United States

View all 15 locations

View Trial Details

Completed

Tislelizumab in Addition to BACE in Patients with NSCLC

NCT05058560

Conditions: NSCLC
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Hennan, China

View Trial Details

Completed

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

NCT05021328

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +6 more
Locations: Hubei Cancer Hospital Wuhan, Hubei, China

View Trial Details

Completed

An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network

NCT04564079

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Centre hospitalier universitaire Dr-Georges-L.-Dumont Moncton, New Brunswick, Canada

The Moncton Hospital Moncton, New Brunswick, Canada

The Ottawa Hospital Ottawa, Ontario, Canada

Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration

NCT06766565

Conditions: NSCLC
Locations: Zongyang Yu Fujian, Fuzhou, China

View Trial Details

Completed

Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation

NCT05146219

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +11 more
Locations: National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Completed

Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects

NCT06255951

Conditions: NSCLC
Locations: Yali Liu Guangdong, Shantou, China

View Trial Details

Completed

A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 Inhibitor

NCT04691388

Conditions: NSCLC
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Completed

Study to Evaluate D-1553 in Subjects With Lung Cancer

NCT05383898

Conditions: NSCLC
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

Zhejiang Cancer Hospital, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China

View Trial Details

Completed

Descriptive Observational Study ALK-2016-CPHG

NCT03718117

Conditions: ALK Gene Rearrangement or ROS1 Gene Rearrangement, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Centre Hospitalier Intercommunal du Pays d'Aix-Pertuis,Service de Pneumologie Aix-en-Provence, France

Clinique de l Europe Amiens, France

Hopital Robert Ballanger, Service de Pneumologie Aulnay-sous-Bois, France

Centre Hospitalier d Avignon Avignon, France

View all 26 locations

View Trial Details